Literature DB >> 1533556

Growth hormone deficiency in Down's syndrome children.

S Castells1, C Torrado, W Bastian, K E Wisniewski.   

Abstract

Down's syndrome (DS) children have been reported to have severe postnatal growth arrest and microcephaly. To determine if growth hormone (GH) deficiency plays a role in growth retardation in DS, 20 children were studied. The subjects (13 boys, 7 girls) were aged between 15 months and 13.9 years, had a height SDS ranging from -1.19 to -5.48, weight SDS ranging from -0.21 to -4.58, head circumference SDS ranging from -0.40 to -6.6, and a skeletal age ranging from 0.9 to 4.6 SD below the mean for normal children of same age and sex. GH was evaluated by levodopa (125 mg up to 15 kg, and 250 mg between 15-30 kg), clonidine (0.15 mg m-2) stimulation tests and hGH secretory patterns by the integrated 24 h. GH concentration (IC-GH) using a constant withdrawal pump with continuous blood collection every 30 min. The serum concentrations were: TSH, 0.7-8.0 mIU ml-1 (0.2-5.5); T4, 6.6-14.3 micrograms dl-1 (5-12); T3, 95-254 ng dl-1 (85-185); LH, less than 2.0-8.3 mIU ml-1 (less than 3); FSH, less than 1.3-7.2 mIU ml-1 (less than 3); testosterone, less than 30 ng dl-1 (5-35); estradiol, less than 5 ng dl-1 (less than 5-25); prolactin, 35.7-2.9 (F: 5-25; m 5-15); and somatomedin-C (Sm-C), 0.14-1.98 U ml-1 (0.08-5.90) (normal values in brackets). Peak serum GH after levodopa and clonidine was found to be below 10 ng ml-1 for both stimulatory tests in seven out of the 20 children studied. Twelve children showed a disparity between levodopa and clonidine testing. Of the 12 children, peak serum GH after levodopa was found to be below 10 ng ml-1 in five children; and peak serum GH after clonidine was found to be below 10 ng ml-1 in six. One child had a clonidine peak increase in serum GH concentration exactly 10 ng ml-1, but had a 12 h IC-GH of 1.5 ng ml-1 (N greater than 3.2). Two children with peak GH after clonidine above 10 ng ml-1 had a 24 h IC-GH of 0.7 and 1.3 ng ml-1. A fourth child who had peak GH concentrations above 10 ng ml-1 with levodopa and clonidine had a 12 h IC-GH of 0.5 ng ml-1.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1533556     DOI: 10.1111/j.1365-2788.1992.tb00469.x

Source DB:  PubMed          Journal:  J Intellect Disabil Res        ISSN: 0964-2633


  4 in total

1.  Relationship between growth and intelligence quotient in children with Down syndrome.

Authors:  Anna Kłosowska; Agnieszka Kuchta; Agnieszka Ćwiklińska; Kornelia Sałaga-Zaleska; Maciej Jankowski; Przemysław Kłosowski; Arkadiusz Mański; Michał Zwiefka; Paulina Anikiej-Wiczenbach; Jolanta Wierzba
Journal:  Transl Pediatr       Date:  2022-04

2.  Evolved developmental homeostasis disturbed in LB1 from Flores, Indonesia, denotes Down syndrome and not diagnostic traits of the invalid species Homo floresiensis.

Authors:  Maciej Henneberg; Robert B Eckhardt; Sakdapong Chavanaves; Kenneth J Hsü
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

3.  Diabetic retinopathy in Down's syndrome.

Authors:  T Fulcher; M Griffin; S Crowley; R Firth; R Acheson; N O'Meara
Journal:  Br J Ophthalmol       Date:  1998-04       Impact factor: 4.638

4.  Is sweat testing for cystic fibrosis feasible in patients with down syndrome?

Authors:  Katharina Ruf; Antonia Demerath; Helge Hebestreit; Steffen Kunzmann
Journal:  BMC Pulm Med       Date:  2018-01-16       Impact factor: 3.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.